Table 2 FDA-approved nanodrugs in the market
From: Nanotechnology advances towards development of targeted-treatment for obesity
Nanodrug tradename | Nanocarrier | Drug | Application | Company | ||
|---|---|---|---|---|---|---|
Abraxane | Albumin NPs | Paclitaxel | Breast cancer, metastatic pancreatic cancer, non-small cell lung cancer | Celgene | ||
Albelcet | Liposomes | Amphotericin B | Fungal infection | Sigma-Tau | ||
Curosurf | Poractant alfa | Respiratory distress syndrome | Chiesi USA | |||
Doxil | Doxorubicin | Karposi’s sarcoma, ovarian cancer, multiple myeloma | Janssen | |||
DepoDur | Morphine sulphate | Postoperative analgesia | Pacira Pharmaceuticals | |||
Marqibo | Vincristine sulfate | Acute lymphoid leukemia | Talon Therapeutics | |||
Thermodox | Doxorubicin | Hepatobiliary tumors | Celsion corp | |||
Copaxone | Polymeric NPs | Glatiramer acetate | Multiple sclerosis | Teva Pharmaceuticals | ||
Neulasta | Pegfilgrastim | Neutropenia | Amgen | |||
Paclical | Micelle NPS | Paclitaxel | Ovarian cancer | Oasmia Pharmaceutical | ||
Rapamune | Nanocrystals | Sirolimus | Lymphangioleiomyomatosis and an immunosuppressants | Elan Nanosystems (now Alkermes) | ||
Emend | Aprepitant | Prevent nausea and vomiting after surgery or chemotherapy | Merck | |||
Tricor | Fenofibrate | Reduces cholesterol and TAGs | AbbVie | |||
Feraheme | Inorganic NPs | Ferumoxytol | Anemia associated with chronic kidney disease | AMAG Pharmaceuticals | ||